Detection of renal allograft rejection using blood oxygen level-dependent and diffusion weighted magnetic resonance imaging: a retrospective study by unknown
Liu et al. BMC Nephrology 2014, 15:158
http://www.biomedcentral.com/1471-2369/15/158RESEARCH ARTICLE Open AccessDetection of renal allograft rejection using blood
oxygen level-dependent and diffusion weighted
magnetic resonance imaging: a retrospective
study
Guangyi Liu1,2, Fei Han1*, Wenbo Xiao3, Qidong Wang3, Ying Xu1 and Jianghua Chen1*Abstract
Background: Acute rejection (AR) and acute tubular necrosis (ATN) are main causes of early renal allograft
dysfunction. Blood oxygen level-dependent magnetic resonance imaging (BOLD MRI) and Diffusion weighted (DW)
MRI can provide valuable information about changes of oxygen bioavailability and water diffusion by measuring
R2* or apparent diffusion coefficient (ADC) respectively. We aimed to determine the value of BOLD MRI and DW
MRI in detecting causes for early allograft dysfunction in renal allograft recipients.
Methods: Fifty patients received renal allografts from deceased donors were analyzed, including 35 patients with
normal renal function (control group), 10 AR patients and 5 ATN patients. Cortical R2* (CR2*) and medullary R2*
(MR2*) were measured by BOLD MRI. Ten diffusion gradient b values (0, 5, 10, 20, 50, 100, 200, 400, 800, 1200s/
mm2) were used in DW MRI. ADC values were measured in renal cortex (CADC) and medulla (MADC). CADCl and
MADCl were measured under low b values (b ≤ 200 s/mm
2), while CADCh and MADCh were measured under
high b values (b > 200 s/mm2).
Results: MR2* was significantly lower in AR group (18.2 ± 1.5/s) than control group (23.8 ± 5.0/s, p = 0.001) and ATN
group (25.8 ± 5.0/s, p = 0.004). There was a tendency of lower levels on CADCl, MADCl, CADCh or MADCh in AR
group than in control group. There were no differences on ADC values between AR group and ATN group.
Conclusions: BOLD MRI was a valuable method in detection of renal allografts with acute rejection.Background
Kidney transplantation is the preferred treatment for
most patients with chronic renal failure. Although ad-
vances in the skill of surgery and pharmacotherapy have
led to improvement of the first-year renal graft survival,
acute rejection (AR) and acute tubular necrosis (ATN)
remain to be the main causes of early kidney allograft
dysfunction [1]. Percutaneous allograft biopsy is the
standard diagnostic method, but it is not suitable for* Correspondence: hanf8876@gmail.com; chenjianghua@zju.edu.cn
1Kidney Disease Center, First Affiliated Hospital, College of Medicine,
Zhejiang University; Key Laboratory of Kidney Disease Prevention and
Control Technology, Zhejiang Province; The Third Grade Laboratory under
the National State Administration of Traditional Chinese Medicine, Hangzhou,
China
Full list of author information is available at the end of the article
© 2014 Liu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.dynamic monitoring due to the invasive nature. A non-
invasive method is promising.
Blood oxygen level-dependent magnetic resonance
imaging (BOLD MRI) is based on the paramagnetic
properties of deoxyhemoglobin, which generates mag-
netic moments by its unpaired electrons in a magnetic
field. The apparent relaxation rate denoted as R2* is pro-
portional to the deoxyhemoglobin concentration. The
increased R2* value implies increased deoxyhemoglobin
level and decreased oxygen bioavailability in tissues [2].
Djamali et al. found BOLD MR images of renal allograft
underwent AR had characteristic changes, which were
related to the pathologic changes in renal allografts [3].
The previous study in our center found that in post-
transplantation patients, R2* value in renal medulla sig-
nificantly increased in ATN allografts and decreased in
AR allografts compared with allografts with normalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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covery of ATN or AR in dynamic follow-up [4].
Diffusion weighted (DW) MRI detects the change of
Brownian motion of water protons in tissues and pro-
vides quantification of the change by calculating appar-
ent diffusion coefficient (ADC) from DW images [5]. It
simultaneously provides information on microcirculation
perfusion. The microcirculation perfusion and water
transportation are prominent physiological activities in
kidney and the change of these activities may cause sig-
nificant change of DW MRI signals. In transplanted rat
kidneys, Yang et al. found that ADC values in renal cor-
tex and medulla decreased significantly during angioten-
sin II-induced reduction in renal blood flow [6]. They
also found allografts exhibited decreased ADC values
while isografts exhibited similar ADC values compared
with native kidneys [6]. Thoeny et al. found that ADC
value was almost identical in the medulla and cortex of
renal allografts in post-transplantation patients, while in
human native kidneys ADC value was higher in the cor-
tex than in the medulla [7].
Thus, BOLD MRI and DW MRI provide valuable infor-
mation about the change of oxygen bioavailability and
water diffusion in renal allografts. In this study we try to
determine the value of BOLD MRI and DW MRI at 3 T in
renal allograft recipients with early allograft dysfunction.
Methods
Study design
This is a retrospective study. The study protocols con-
formed to the provisions of the Declaration of Helsinki.
The Ethic Committee of our hospital approved the proto-
cols and all patients were informed and gave written con-
sent. We included renal allograft recipients that received
renal transplantation from deceased donors in our center
and were willing to accept MRI examination between April
2010 and February 2011. The patients were scheduled to
receive MRI 2–3 weeks after transplantation. The patients
with AR or ATN received MRI within 3 days before or
after percutaneous allograft biopsy. Totally, fifty patients’
data were analyzed. There were 35 patients who had stable
normal renal function and no diagnosed episodes of AR or
ATN during follow-up (control group), 10 AR patients
(AR group) and 5 ATN patients (ATN group). The diagno-
sis of AR and ATN was confirmed by percutaneous allo-
graft biopsy. In AR group, there were 6 patients with acute
T-cell mediated rejection (TMR) and 4 patients with acute
antibody-mediated rejection (AMR) according to Banff ’05
criteria [8]. For ATN patients, the diagnosis was patho-
logically based on vacuolar degeneration or necrosis in dif-
fuse or multifocal renal tubular epithelium and confirmed
by clinical course of recovery without intensive immuno-
suppressive therapy such as methylprednisolone impulse,
anti-T lymphocyte antibodies and plasma exchange. Allthese patients received combination of calcineurin-
inhibitors, mycophenolate mofetil and prednisone as main-
taining immunosuppression. Prednisone (10-15 mg) and
mycophenolate mofetil (1.5 g) were administrated to the
patients daily after 10 days post-operation. The dose of
calcineurin-inhibitors such as tacrolimus and cyclosporin A
was adjusted according to renal function and complica-
tions, and their trough blood concentration was monitored.
For AR patients, we gave intensive immunosuppressive
therapy such as methylprednisolone impulse, anti-T
lymphocyte antibodies and plasma exchange only after
renal biopsy and MRI. For ATN patients, no such in-
tensive immunosuppressive therapy was prescribed.
No angiotensin-converting enzyme inhibitors (ACEIs)
or angiotensin II receptor blockers (ARBs) were used
in any group. For hypertensive patients, we used
calcium-channel blockers, β receptor blockers or cloni-
dine to keep blood pressure below 160/100 mmHg.
All the patients were refrained from water or intraven-
ous transfusion 4 hours before MRI and had no diuretic
agents 12 hours before MRI. The mean arterial pressure
(MAP) was measured right before MRI. During imaging,
the patients had no oxygen inhalation and digital oxygen
saturation was above 98%. The clinical results such as
hemoglobin, serum creatinine and trough blood concen-
tration of cyclosporin or tacrolimus were measured on
the imaging day. The 24-hour urine output on the im-
aging day was recorded.
MRI parameters
MRI was performed using a 3.0 Tesla system (GE Signa
Horizon, Milwaukee, USA). For BOLD MRI, Echo-
planar imaging sequence was performed to acquire im-
ages in coronal section during breath holds of 15 sec-
onds. The parameters were as follows: repetition time
150 ms, TE 16 echo, echo time 2.5 ms, Flip angle 30 de-
gree, Bandwidth ±31.25 kHz, Matrix 128 × 128, number
of signals acquired 1, field of view 35 cm, thickness
6.0 mm, space 1.0 mm. Color map of R2* value was gen-
erated using software of T2* map in Functools 2 on MR
working station. R2* values were measured using re-
gions of interest (ROI) tool. Five to eight ROIs of the
same size were placed in cortical region and in medul-
lary region respectively, using regular T2 weighted
image as reference. R2* measurements of all patients
were completed by one radiologist unknowing the clin-
ical or pathological data.
For DW MRI, Echo-planar imaging sequence was per-
formed to acquire 16 DW images in transverse section.
The parameters were as follows: repetition time 100 ms,
echo time 2.5 ms, TE 65.5 ms, Flip angle 30 degree,
Bandwidth ±31.25 kHz, Matrix 192 × 128, number of sig-
nals acquired 1, field of view 36 cm, thickness 6.0 mm,
space 1.0 mm. The following 10 diffusion gradient b values
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The images acquired under b value less than or equal to
200 s/mm2 were overlaid as the image of low b values,
while the images acquired under b value greater than
200 s/mm2 were overlaid as the image of high b values.
Color map of ADC value was generated using MADC soft-
ware in Functools 2 on MR working station. According to
the b values, the map was generated separately into ADC
map of low b values (b value less than or equal to 200 s/
mm2) and ADC map of high b values (b value greater than
200 s/mm2). ADC values were measured using regions of
interest (ROI) tool. Five to eight ROIs of the same size were
placed in cortical region and in medullary region respect-
ively, using regular T2 weighted image as reference. ADC
measurements of all patients were completed by one radi-
ologist unknowing the clinical or pathological data.
Data analysis
The analysis was performed by SPSS 16.0 software (SPSS
Inc, Chicago, IL, USA). Numerical results were expressed
as mean ± standard deviation, and were compared between
groups using one-way analysis of variance (ANOVA) with
POST-HOC test to perform pairwise multiple comparisons.
The categorical data was expressed as counts or percent-
ages and was compared using χ2 (Fisher’s exact test).
Mann–Whitney test was used for nonparametric compari-
sons. Multinomial linear regression was used to determine
the influence factors of R2* value or ADC value. Spearman
correlation was used to determine the relation between R2*
value and ADC value.
Results
Clinical characteristics
The clinical characteristics of patients in AR group, ATN
group and control group were shown in Table 1. TheTable 1 The clinical characteristics of patients in AR group, A
Group Control
Case number 35
Age (years) 34.6 ± 10.1
Male: Female 28:7
Post-operation days 12.7 ± 6.4
Post-biopsy days NA
Urine output (l/24 hours) 2.36 ± 0.44
sCr (μmol/l) 88.8 ± 21.9
Hb (g/l) 104.2 ± 15.7
MAP (mmHg) 95.3 ± 10.9
Tacrolimus: CsA 30:5
Tacrolimus trough concentration (ng/ml) 7.5 ± 1.6
CsA trough concentration (ng/ml) 320.5 ± 64.8
Note: sCr, serum creatinine; Hb, hemoglobin; MAP, mean arterial pressure; CsA, cycl
#p < 0.05 compared with the ATN group.patients in AR group received MRI in 31.1 ± 44.5 days (3
to 154 days) post-operation, later than that in control
group (12.7 ± 6.4 days), while the patients in ATN group
received MRI in 12.0 ± 5.3 days (7 to 21 days) post-
operation. The patients in AR group and ATN group had
higher levels of serum creatinine and MAP, and lower
levels of hemoglobin and urine output compared with
control group. All the patients in ATN group used tacroli-
mus, and their mean trough concentration level was lower
than that in control group and AR group.
BOLD MRI data analysis
The typical R2* maps of renal allografts in control
group, AR group and ATN group were shown in Figure 1
and the average R2* values were shown in Table 2. In
the color R2* maps of the coronal section of renal allo-
grafts, change of color from blue to green, orange, and
then red represents the change of R2* value from lower
to higher. In normal functioning allograft, renal cortex
had the lowest R2* value, and the R2* value increased
gradually from cortex to medulla. There were more blue
regions in the medulla of AR allografts and more green
regions in the medulla of ATN allografts, compared with
those in normal allografts.
Medullary R2* (MR2*) value was significantly lower in
AR group (18.2 ± 1.5/s) than that in control group (23.8 ±
5.0/s, p = 0.001) and ATN group (25.8 ± 5.0/s, p = 0.004).
There were no significant differences on cortical R2*
(CR2*) value among 3 groups. These results implied that
the level of oxygen bioavailability in renal medulla in-
creased in AR allografts compared with normal allografts
and ATN allografts.
We did a follow-up BOLD MRI in 26 patients in con-
trol group at 34.5 ± 6.5 days post-operation. The paired-
samples T test showed there were significant increase ofTN group and control group
AR ATN
10 5
36.3 ± 9.2 37.6 ± 11.5
6:4 4:1
31.1 ± 44.5* 12.0 ± 5.3
1.1 ± 3.9 1.4 ± 3.4
1.67 ± 0.96* 1.40 ± 0.66*
256.3 ± 173.5* 322.8 ± 179.1*
88.6 ± 15.1* 81.8 ± 14.4*
109.9 ± 11.2* 107.7 ± 15.6*
6:4 5:0
8.4 ± 2.4# 4.8 ± 1.6*
238.6 ± 89.6 NA
osporine A; NA, not applicable. *p < 0.05 compared with the control group;
Figure 1 The representative R2* maps and ADC maps of renal allografts in AR group, ATN group and control group. A, the
representative R2* map (A1) and ADC maps (A2, ADC map of low b values; A3, ADC map of high b values) of normal control allograft; B, the
representative R2* map (B1) and ADC maps (B2, ADC map of low b values; B3, ADC map of high b values) of AR allograft; C, the representative
R2* map (C1) and ADC maps (C2, ADC map of low b values; C3, ADC map of high b values) of ATN allograft. In R2* maps, the coronal section of
the kidney is shown. The change of color from blue to green, orange, and then red represents the change of R2* value from lower to higher.
There were more blue regions in the medulla of AR allograft (B1) and more green regions in the medulla of ATN allograft (C1), compared with
normal control allograft (A1). In ADC maps, the transverse section of the kidney is shown. The change of color from green to orange, and then
red represents the change of ADC value from lower to higher. There were less red regions and more green regions in AR allograft (B2, B3) and
ATN allograft (C2, C3) compared with normal control allograft (A2, A3), regardless of low or high b values.
Liu et al. BMC Nephrology 2014, 15:158 Page 4 of 7
http://www.biomedcentral.com/1471-2369/15/158serum creatinine (99.0 ± 23.7 μmol/l vs 88.0 ± 23.9 μmol/l,
P = 0.004) and decreasing tendency of MR2* (22.0 ± 3.8/s
vs 24.0 ± 5.4/s, P = 0.077) at the time of follow-up MRI
compared with the first MRI (Table 3). However the MR2*
value of the follow-up BOLD MRI in control group was
higher than that in AR group (22.0 ± 3.8/s vs 18.2 ± 1.5/s,
P = 0.0044).Table 2 The ADC and R2* values of renal allografts in AR
group, ATN group and control group
Parameter Control AR ATN
CR2* (1/s) 18.4 ± 4.4 16.6 ± 2.1 17.7 ± 3.7
MR2* (1/s) 23.8 ± 5.0 18.2 ± 1.5*# 25.8 ± 5.0
CADCl (×10
−3 mm2/s) 3.42 ± 0.36 3.04 ± 0.21* 2.98 ± 0.25*
MADCl (×10
−3 mm2/s) 3.46 ± 0.42 2.90 ± 0.32* 2.85 ± 0.25*
CADCh (×10
−3 mm2/s) 1.89 ± 0.23 1.53 ± 0.09* 1.72 ± 0.12
MADCh (×10
−3 mm2/s) 1.88 ± 0.28 1.53 ± 0.08* 1.69 ± 0.13
Note: CR2*, cortical R2*; MR2*, medullary R2*; ADC, apparent diffusion
coefficient; CADC, cortical ADC; MADC, medullary ADC. The value of CADCl and
MADCl were collected from the ADC map of low b values and the values of
CADCh and MADCh were collected from the ADC map of high b values.
*p < 0.05 compared with the control group; #p < 0.05 compared with the
ATN group.DW MRI data analysis
The typical ADC maps of renal allografts in control
group, AR group and ATN group were shown in Figure 1
and the average values of ADC were shown in Table 2.
In the color ADC maps of the transverse section of renal
allografts, change of color from green to orange, and
then red represents the change of ADC value from lower
to higher. In AR and ATN group, there were less red re-
gions and more green regions both in the cortex and in
the medulla of renal allografts compared with those in
control group.Table 3 The comparison of R2* values obtained from the
first BOLD MRI and the follow-up BOLD MRI in 26 patients
in control group
First MRI Second MRI P value
Post-operation days 10.5 ± 1.3 34.5 ± 6.5
CR2* (1/s) 18.4 ± 5.1 16.9 ± 1.3 0.151
MR2* (1/s) 24.0 ± 5.4 22.0 ± 3.8 0.077
Serum Creatinine (μmol/L) 88.0 ± 23.9 99.0 ± 23.7 0.004
Note: CR2*, cortical R2*; MR2*, medullary R2*.
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ADC (CADC) value and medullary ADC (MADC) value
in each group. The values of CADCl and MADCl were
measured from ADC map of low b values (b value less
than or equal to 200 s/mm2) and the values of CADCh
and MADCh were measured from ADC map of high b
values (b value greater than 200 s/mm2). The values of
CADCl, MADCl, CADCh and MADCh in AR group were
significantly lower than those in control group. Only the
values of CADCl and MADCl in ATN group were lower
than those in control group. But there were no differences
on ADC values between AR and ATN group.
We did a follow-up DW MRI in 14 patients in control
group at 34.6 ± 7.8 days post-operation. The paired-samples
T test showed an increased serum creatinine level (98.1 ±
17.7 μmol/l vs 82.7 ± 21.0 μmol/l, P = 0.003) and no signifi-
cant differences on CADCl, MADCl, CADCh or MADCh at
the time of follow-up DW MRI compared with the first
DW MRI (Table 4). However different from the results of
the first DW MRI, in the follow-up DW MRI, there were
no significant differences between CADCl, MADCl,
CADCh or MADCh in control group and those in AR
group (P = 0.15, 0.15, 0.09, 0.18 respectively).
The influence factors of R2* value or ADC value
Multinomial linear regression analysis revealed that clinical
characteristics including age, post-operation days, post-
biopsy days, levels of serum creatinine, hemoglobin, urine
output and MAP were not the independent influence fac-
tors for CR2*, MR2*, CADCl, MADCl, CADCh or MADCh.
Spearman correlation analysis revealed that there were
positive correlation between MR2* and CADCh (r = 0.4,
p = 0.004), and MR2* and MADCh (r = 0.332, p = 0.018).
Discussion
The current study showed MR2* value was significantly
lower in AR allografts compared with normal allografts
and ATN allografts. In BOLD MRI, decreased R2* value
implied increased oxygen bioavailability in tissues [2], soTable 4 The comparison of ADC values obtained from the
first DW MRI and the follow-up DW MRI in 14 patients in
control group
First MRI Second MRI P value
Post-operation days 10.6 ± 1.3 34.6 ± 7.8
CADCl (×10-3 mm2/s) 3.47 ± 0.28 3.29 ± 0.50 0.290
MADCl (×10-3 mm2/s) 3.46 ± 0.25 3.21 ± 0.59 0.148
CADCh (×10-3 mm2/s) 1.78 ± 0.15 1.78 ± 0.44 0.962
MADCh (×10-3 mm2/s) 1.75 ± 0.18 1.78 ± 0.56 0.821
Serum Creatinine (μmol/L) 82.7 ± 21.0 98.1 ± 17.7 0.003
Note: ADC, apparent diffusion coefficient; CADC, cortical ADC; MADC,
medullary ADC. The value of CADCl and MADCl were collected from the ADC
map of low b values and the values of CADCh and MADCh were collected from
the ADC map of high b values.decreased MR2* value in AR allografts indicated that the
level of oxygen bioavailability increased in the medulla
of AR allografts. One reason may be the decreased
glomerular filtration rate (GFR) in AR episodes, which
causes decreased production of original urine and then
less tubular reabsorption, and subsequent reduced oxy-
gen consumption. Another possibility is the change of
oxygen delivery by blood supply. Wentland et al. used
MRI to measure renal cortical and medullary perfusion,
oxygen bioavailability in the kidneys of porcine models
and found that R2* values decreased in renal cortex and
medulla when the local blood perfusion increased [9].
Acute rejection causes obvious inflammation in renal
medulla, which may increase blood shunting to the me-
dulla [10]. However, recent studies using perfusion MRI
revealed that blood perfusion both in renal cortex and in
medulla decreased significantly in rejected allografts
compared with that in normal allografts [11,12]. So de-
creased oxygen consumption may be the main cause for
increased oxygen bioavailability in renal medulla. Clinic-
ally, BOLD MRI has been applied in a few studies that
showed MR2* values were significantly decreased in AR
allografts compared with those in normal allografts
[3,4,11,13]. Djamali et al. found changes of BOLD MRI
were related to the pathologic changes in AR allografts,
and AR allografts with vascular injury such as type IIA
or peritubular capillary C4d positive AR had the lowest
MR2* level [3].
DW MRI provides information of water diffusion and
microcirculation perfusion at the same time. In human
native kidneys, CADC values were higher than MADC
values [7,14], however in renal allografts there were no
significant differences between CADC and MADC [7].
The b value is the sensitive coefficient of diffusion and
the higher b value represents more sensitive imaging of
diffusion. Under low b values, ADC values are influ-
enced by both diffusion and blood perfusion; while
under high b values, the influence of blood perfusion is
avoided [14]. In the current study, both ADCl and ADCh
values were lower in AR allografts and only ADCh values
were lower in ATN allografts, compared with those in
normal allografts. Perfusion MRI proved that there was
significant decrement on renal perfusion in AR allografts
but not in ATN allografts [10,11]. The current results
supported that both levels of water diffusion and blood
perfusion were impaired in AR allografts, whereas only
level of water diffusion was impaired in ATN allografts.
Recently, a few studies evaluated the diagnostic value of
DW MRI in acute renal allograft dysfunction [15,16]. One
study compared renal allografts under AR(n = 10), ATN
(n = 7) and immunosuppressive toxicity(n = 4) with 49 pa-
tients with stable renal allograft function [15]. They found
that ADC values of allografts under ACR, ATN and im-
munosuppressive toxicity, respectively, were significantly
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significant differences in ADC values among ACR, ATN,
and immunosuppressive toxicity groups [15]. Another
study performed DW MRI in 15 renal allograft recipients
including 10 with stable function and 5 with renal dys-
function (4 AR and 1 ATN) [16]. They separately analyzed
ADC values by the influence of diffusion or microcircula-
tion perfusion, and found that ADC values due to perfu-
sion decreased to less than 12% in allografts with renal
dysfunction and were correlated with the level of creatin-
ine clearance [16].
Presently most kidney MRI studies were performed at
1.5 T. Higher field strengths may have the advantages such
as higher signal-to-noise ratios, faster imaging and better
spatial resolution [17]. Park et al. performed BOLD MRI
at 3 T in 8 normal functioning renal allografts and 4 AR
allografts, and found MR2* values were significantly lower
in AR allografts than in normal allografts at different gra-
dient echo of 8, 16 or 20[18]. Lanzman et al. performed
DW MRI at 3 T in 40 kidney recipients, divided into one
group with good or moderate kidney function (GFR >
30 ml/min/1.73 m2, n = 23) and the other group with im-
paired kidney function (GFR ≤ 30 ml/min/1.73 m2, n = 17)
[19]. They found both CADC and MADC values were sig-
nificantly lower in allografts with impaired kidney func-
tion, and another parameter named fractional anisotropy
of renal medulla was significantly lower in recipients
whose kidney function did not recover in 6 months than
in those with stable kidney function [19]. There were no
reports about the comparative effects between 1.5 T and
3 T in kidney imaging now. However, a study performing
BOLD MRI of parotid glands at 1.5 T or 3 T for the same
group of patients was reported [20]. It showed that BOLD
MRI at 3 T, but not at 1.5 T, was able to detect changes of
R2* value during gustatory stimulation, which was consist-
ent with an increase in oxygen consumption during saliva
production [20].
This study had some limitations. First, although we re-
stricted water or intravenous transfusion 4 hours before
MRI and diuretic agents 12 hours before MRI, we did
not measure the exact hydration status in individual pa-
tients before MRI. Commonly, there was water retention
in patients with impaired glomerular filtration such as
AR or ATN patients. This may lead to decreased MR2*
[21], while different hydration states do not significantly
influence ADC values [22]. Second, the time of MRI in
AR patients was later than patients with normal renal
function and ATN patients. The R2* values and ADC
values may change following the recovery of renal allo-
grafts such as improvements in tissue edema and inflam-
mation. However, we did a follow-up BOLD MRI in 26
patients with normal renal function at 34.5 days after
operation, the same as that in AR group. A negative
correlation betweenMR2* and days post-operation wasobserved, however, the MR2* value in the follow-up
MRI was 22.0 ± 3.8/s, higher than that in AR patients
(18.2 ± 1.5/s). We also did a follow-up DW MRI in 14
patients in control group and found no differences on
ADC values between the first DW MRI and the follow-
up DW MRI. However, there were no significant differ-
ences on ADC values between the follow-up DW MRI
in control group and that in AR group. Due to the rela-
tively small P values obtained, the reason may be the
limited cases at the time of follow-up DW MRI in con-
trol group. Third, this was a retrospective analysis in one
center with limited cases. The patients in control group
were not subjected to renal biopsy to evaluate possible
subclinical rejection. A well-designed perspective study
is necessary to prove the diagnostic values of BOLD
MRI and DW MRI in renal allografts.
Conclusions
BOLD MRI was a valuable method in detection of renal
allografts with AR, and its diagnostic values need to be
proved by a well-designed, large, perspective study.
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